GlassScriptPhysician profile
Devin Mangold
NPI 1326427444
$7,533.03
in general payments reported to CMS, 2019-2025
11 companies · $23.00 in 2025
The $23.00 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,235 · 2020: $22.75 · 2021: $466 · 2022: $1,200 · 2023: $3,586 · 2025: $23.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,458 · Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,457.66 |
| Food and Beverage | $1,151.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cornerstone Medical Associates, INC. | $3,144.08 | 2022-2025 | |
| Arthrex, INC. | $1,648.26 | 2023 | |
| Medical Device Business Services, INC. | $1,473.78 | 2019 | |
| Stryker Corporation | $490.56 | 2019-2021 | |
| Depuy Synthes Sales INC. | $227.30 | 2019 | |
| Paragon 28, INC. | $152.10 | 2020-2021 | |
| Exactech, INC. | $133.37 | 2021 | |
| Zimmer Biomet Holdings, INC. | $124.41 | 2021 | |
| Wright Medical Technology, INC. | $122.49 | 2019 | |
| Bioventus LLC | $16.68 | 2023 | Exogen Ultrasound Bone Healing System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$60,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Mangold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.